EP MEDICAL ApS: Financial statements 2017
CVR: 29631905
Source: annual report 2017, Danish Business Authority
01/01/2017 – 31/12/2017
EP MEDICAL ApS (CVR 29631905) has filed annual accounts for 2017. In 2017, the company reported revenue of DKK 438,492 and a net result of DKK -206,219 compared with DKK -187,179 the year before. That is an increase of 3.1% compared with the year before. The profit margin was -47%. Equity in the 2017 report amounted to DKK 7,457,998. The solvency ratio was 99%. The company had 1 employee in the financial year.
- Revenue
- DKK 438,492
- Gross Profit
- DKK 194,327
- Profit/Loss
- DKK -206,219
- Equity
- DKK 7,457,998
- Total Assets
- DKK 7,533,672
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2017 | 438 t. | 194 t. | -206 t. | 7.5 mio. | 1 |
| 2016 | 425 t. | 196 t. | -187 t. | 7.8 mio. | 1 |
| 2015 | 361 t. | 134 t. | -206 t. | 8.1 mio. | 1 |
| 2014 | 866 t. | 534 t. | 303 t. | 8.5 mio. | 1 |
| 2013 | 636 t. | 310 t. | -60 t. | 8.4 mio. | 1 |
Official annual report
Keep an eye on EP MEDICAL ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2017
EP MEDICAL ApS has published its annual report for 2016. Revenue came to DKK 425,251, and the net result was DKK -187,179.
As of February 15, 2017, DELOITTE STATSAUTORISERET REVISIONSPARTNERSELSKAB has stepped down as auditor of EP MEDICAL ApS.
About EP MEDICAL ApS
EP MEDICAL ApS is a Danish company of the type Anpartsselskab based in København V, founded in 2006. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named EP MEDICAL CONSULTING ApS and REFLAB HOLDING ApS. The management consists of Eva Valbjørn Sørensen. The company is owned by Per Stahl Skov and Eva Valbjørn Sørensen. The company has 1 employee (2026). In 2025, the company reported a gross profit of DKK 265,299 and a net result of DKK -348,750 compared with DKK 182,500 the year before. Equity in the 2025 report amounted to DKK 5,784,791.